8-K
filed July 27, 2023, 7:59 PM ET
ticker ITGR
CIK 0001114483
earnings
confidence high
sentiment positive
materiality 0.75
Integer Holdings Q2 sales up 14% to $400M, raises FY2023 outlook
Integer Holdings Corp
2023-Q2 EPS reported
$1.10
revenue$778,829,000
- GAAP diluted EPS $0.71 vs $0.62 prior year; adjusted EPS $1.14 vs $1.04.
- Sales growth driven by Cardio & Vascular (+15%), Cardiac Rhythm (+13%), Advanced Surgical (+17%).
- FY2023 sales outlook raised to 11-13% growth (midpoint 12%); adjusted operating income growth outlook raised to 17-21%.
- Total debt increased to $985M due to $500M convertible notes and $35M capped call; leverage ratio 3.5x.
- CEO cites improving supply chain and labor environment; strong customer demand across product lines.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Integer Holdings Corp reported the full year 2023 results: revenue $1,530 to $1,550, net income $83 to $89, EPS $2.45 to $2.65. Guidance raised.
- Period
- the full year 2023
- Revenue
- $1,530 to $1,550
- Net income
- $83 to $89
- EPS
- $2.45 to $2.65
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
in the energy market. 2023 Outlook (a) (dollars in millions, except per share amounts) GAAP Non-GAAP (b) As Reported Change from Prior Year Adjusted Change from Prior Year Sales $1,530 to $1,550 11% to 13% N/A N/A Operating income $152 to $160 25% to 32% $224 to $232 17% to 21% EBITDA N/A N/A $294 to $302 15% to 18% Net income $83 to $89 26% to 37% $143 to $149
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Integer Holdings Corp reported the three months ended June 30, 2023 results: revenue $400 million, net income $24 million, EPS $0.71 per share.
- Period
- the three months ended June 30, 2023
- Revenue
- $400 million
- Net income
- $24 million
- EPS
- $0.71 per share
- Result
- reported results
Exact text from the filing
Second Quarter 2023 Highlights (compared to Second Quarter 2022, except as noted) Sales increased 14% to $400 million, with organic growth of 14%. GAAP net income increased $3 million to $24 million, an increase of 15%. Non-GAAP adjusted net income increased $4 million to $38 million, an increase of 11%. GAAP operating income increased $9 million to $42 million, an increase of 27%. Non-GAAP adjusted operating income increased $10 million to $60 million, an increase of 20%. GAAP diluted EPS increased $0.09 per share to $0.71 per share. Non-GAAP adjusted EPS increased $0.10 per share to $1.14 per share. Adjusted EBITDA increased $10 million to $76 million, an increase of 16%.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.